BUCCASTEM

This brand name is authorized in New Zealand, United Kingdom

Active ingredients

The drug BUCCASTEM contains one active pharmaceutical ingredient (API):

1 Prochlorperazine UNII I1T8O1JTL6 - PROCHLORPERAZINE MALEATE

Prochlorperazine belongs to the phenothiazine group. Prochlorperazine has a wide range of activity arising from its depressant actions on the CNS and its alpha-adrenergic blocking and weaker anti-muscarinic properties. It inhibits dopamine and prolactin-release-inhibitory factor, thus stimulating the release of prolactin. Read about Prochlorperazine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BUCCASTEM M Buccal tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AB04	Prochlorperazine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AB Phenothiazines with piperazine structure
Discover more medicines within N05AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 14656
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5186